Suppr超能文献

用于高灵敏 microRNA 检测的干扰减少生物传感策略。

Interference Reduction Biosensing Strategy for Highly Sensitive microRNA Detection.

机构信息

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau SAR 999078, China.

Zhuhai UM Science and Technology Research Institute, Zhuhai 519031, China.

出版信息

Anal Chem. 2022 Mar 15;94(10):4513-4521. doi: 10.1021/acs.analchem.2c00138. Epub 2022 Mar 2.

Abstract

MicroRNAs are potential biomarkers for human cancers and other diseases due to their roles as post-transcriptional regulators for gene expression. However, the detection of miRNAs by conventional methods such as RT-qPCR, in situ hybridization, northern blot-based platforms, and next-generation sequencing is complicated by short length, low abundance, high sequence homology, and susceptibility to degradation of miRNAs. In this study, we developed a nicking endonuclease-mediated interference reduction rolling circle amplification (NEM-IR-RCA) strategy for the ultrasensitive and highly specific detection of miRNA-21. This method exploits the advantages of the optical properties of long-lived iridium(III) probes, in conjunction with time-resolved emission spectroscopy (TRES) and exponential rolling circle amplification (E-RCA). Under the NEM-IR-RCA-based signal enhancement processes, the limit of detection of miRNA-21 was down to 0.0095 fM with a linear range from 0.05 to 100 fM, which is comparable with the conventional RT-qPCR. Unlike RT-qPCR, the strategy was performed at a lower and constant temperature without heating/cooling cycles and reverse transcription. The strategy could clearly discriminate between matched and mismatched targets, demonstrating high specificity. Moreover, the potential application of this method was demonstrated in cancer cells and mouse serum samples, showing good agreement with RT-qPCR results. Apart from miRNA-21 detection, this platform could be also adapted for detecting other miRNAs, such as let-7a and miRNA-22, indicating its excellent potential for biomedical research and clinical diagnostics.

摘要

微 RNA 作为基因表达的转录后调控因子,是人类癌症和其他疾病的潜在生物标志物。然而,传统方法如 RT-qPCR、原位杂交、基于 Northern blot 的平台和下一代测序等方法检测 miRNA 时,由于 miRNA 长度短、丰度低、序列同源性高和易降解,检测过程较为复杂。在本研究中,我们开发了一种切口内切酶介导的干扰减少滚环扩增(NEM-IR-RCA)策略,用于超灵敏和高度特异性检测 miRNA-21。该方法利用了长寿命铱(III)探针的光学特性优势,结合时间分辨荧光光谱(TRES)和指数滚环扩增(E-RCA)。在基于 NEM-IR-RCA 的信号增强过程中,miRNA-21 的检测限低至 0.0095 fM,线性范围为 0.05 至 100 fM,与传统的 RT-qPCR 相当。与 RT-qPCR 不同,该策略在较低且恒定的温度下进行,无需加热/冷却循环和逆转录。该策略可以清楚地区分匹配和不匹配的靶标,表现出高度的特异性。此外,该方法在癌细胞和小鼠血清样本中的潜在应用表明,与 RT-qPCR 结果具有良好的一致性。除了 miRNA-21 的检测外,该平台还可以用于检测其他 miRNA,如 let-7a 和 miRNA-22,表明其在生物医学研究和临床诊断方面具有巨大的潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验